Acne. Acne
Conditions
Interventions
Intervention 1: Intervention group 1: spironolactone 2% solution. Intervention 2: Intervention group 2: erythromycin 4% solution. Intervention 3: Intervention group 3: spironolactone 2% solution ???
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Aged 18-40 Acne diagnosis by a dermatologist
Exclusion criteria
Exclusion criteria: Pregnancy or breastfeeding during the intervention history of internal diseases, including endocrine diseases causing acne alteration in diet and lifestyle during the study having consumed systemic therapy for acne in the last 4 weeks having consumed oral antibiotics in the last 3 months having consumed topical therapy for acne in the last 2 weeks having consumed isotretinoin, undertaken laser, and peeling in the last 6 months Photosensitivity severe or nodularis acne polycystic ovary syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ??Acne severity index. Timepoint: At the beginning of the study (before the start of the intervention) and 6 and 12 weeks after the start of trial. Method of measurement: Acne severity index (ASI) formula.;Patients' satisfaction with acne recovery. Timepoint: At the beginning of the study (before the start of the intervention) and 6 and 12 weeks after the start of trial. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNika Kianfar
Tehran University of Medical Sciences
Outcome results
None listed